Investor Overview

Description

Morningside was founded in 1986 by the Chan family of Hong Kong to make venture capital and private equity investments. The group is characterized by its long-term outlook in company-building and by its unwavering commitment to acting ethically. As pharmaceutical companies invest in expensive therapies often for diseases of very low incidence, Morningside does not shy away from developing affordable therapies for high-prevalence diseases such as tuberculosis, hepatitis B, asthma, autism and dementia. Long before COVID-19, Morningside has been investing in vaccines, the one medical intervention that has saved more lives in human history than any therapeutic has.

Investor Type
Venture Capital
Founded
1986

Investment Preference

Business Model
B2B
Offering Type
Software
AI Techologies
Sectors

Investment Portfolio

1

Portfolio Companies

Startup

Operating Status

Business Model

Total Funding

AI Employees

Active
B2B
$47,000,000

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

In The News

Sponsored Startup

With dozens of successful projects behind us in numerous business fields, we provide best data science project practices.

© 2021 StartupHub.ai. All rights reserved.

You cannot copy content of this page

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database